Docosahexaenoic acid liposomes for targeting chronic inflammatory diseases and cancer: an in vitro assessment

Autor: Alaarg A, Jordan NY, Verhoef JJF, Metselaar JM, Storm G, Kok RJ

Publikováno v: International Journal of Nanomedicine, Vol Volume 11, Pp 5027-5040 (2016)

Amr Alaarg,1,2 Nan Yeun Jordan,1 Johan JF Verhoef,1 Josbert M Metselaar,2,3 Gert Storm,1,2 Robbert J Kok1 1Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, 2Department of Biomaterials Science an

Externí odkaz: https://doaj.org/article/b15d774cf888422981367685c90fbb00

Polyphosphate nanoparticles on the platelet surface trigger contact system activation.

Autor: Verhoef JJ; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands., Barendrecht AD; Department of Clinical Chemistry and Haematology, University Medical Center Utrecht, Utrecht, The Netherlands., Nickel KF; Department of Molecular Medicine and Surgery, Karolinska Institutet and University Hospital, Stockholm, Sweden.; Institute of Clinical Chemistry and Laboratory Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Dijkxhoorn K; Department of Clinical Chemistry and Haematology, University Medical Center Utrecht, Utrecht, The Netherlands., Kenne E; Department of Molecular Medicine and Surgery, Karolinska Institutet and University Hospital, Stockholm, Sweden., Labberton L; Department of Molecular Medicine and Surgery, Karolinska Institutet and University Hospital, Stockholm, Sweden., McCarty OJ; Department of Biomedical Engineering, Department of Cell & Developmental Biology, Division of Hematology & Medical Oncology, Oregon Health & Science University, Portland, OR; and., Schiffelers R; Department of Clinical Chemistry and Haematology, University Medical Center Utrecht, Utrecht, The Netherlands., Heijnen HF; Department of Clinical Chemistry and Haematology, University Medical Center Utrecht, Utrecht, The Netherlands., Hendrickx AP; Department of Medical Microbiology, University Medical Center Utrecht, Utrecht, The Netherlands., Schellekens H; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands., Fens MH; Department of Clinical Chemistry and Haematology, University Medical Center Utrecht, Utrecht, The Netherlands., de Maat S; Department of Clinical Chemistry and Haematology, University Medical Center Utrecht, Utrecht, The Netherlands., Renné T; Department of Molecular Medicine and Surgery, Karolinska Institutet and University Hospital, Stockholm, Sweden.; Institute of Clinical Chemistry and Laboratory Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Maas C; Department of Clinical Chemistry and Haematology, University Medical Center Utrecht, Utrecht, The Netherlands.

Publikováno v: Blood [Blood] 2017 Mar 23; Vol. 129 (12), pp. 1707-1717. Date of Electronic Publication: 2017 Jan 03.

Questioning the Use of PEGylation for Drug Delivery.

Autor: Verhoef JJ; University of Utrecht, School of Pharmacy and Pharmaceutical Sciences, Utrecht, 3584 CG The Netherlands., Anchordoquy TJ; University of Colorado Denver, Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, CO 80045 USA.

Publikováno v: Drug delivery and translational research [Drug Deliv Transl Res] 2013 Dec; Vol. 3 (6), pp. 499-503.

Differences in spontaneously reported hypersensitivity and serious adverse events for intravenous iron preparations: comparison of Europe and North America.

Autor: Bailie GR; Albany Nephrology Pharmacy Group, Albany College of Pharmacy and Health Sciences, Albany, NY 12208, USA. george.bailie@acphs.edu, Hörl WH, Verhoef JJ

Publikováno v: Arzneimittel-Forschung [Arzneimittelforschung] 2011; Vol. 61 (5), pp. 267-75.